LUMO
Closed
Lumos Pharma Inc
4.34
0.00 (0.00%)
Last Update: 13 Dec 2024 17:30:00
Yesterday: 4.34
Day's Range: 4.34 - 4.34
Send
sign up or login to leave a comment!
When Written:
3.27
Lumos Pharma Inc is a clinical-stage biopharmaceutical company that focuses on developing therapeutics for rare and neglected diseases. The company is headquartered in Austin, Texas, and was founded in 2011. Lumos Pharma is focused on developing small molecule therapeutics that target the underlying biology of rare diseases. The company's lead product candidate, LUM-201, is a potential treatment for Pediatric Growth Hormone Deficiency (PGHD), a rare condition that affects children's growth and development. Lumos Pharma is also developing other product candidates for rare diseases, including LUM-301 for a rare metabolic disorder called Creatine Transporter Deficiency (CTD). The company aims to improve the lives of patients with rare diseases by developing innovative therapies that address the underlying causes of these conditions.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








